[home]
[thesaurus]
Click Here to return To Results
Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008
See this aricle in Pubmed
Article Abstract
Natalizumab treatment was effective and well tolerated in our pediatric patients with RRMS who did not respond to initial immunomodulatory treatments. Therefore, it is a promising second-line therapy for pediatric patients with RRMS.
Related Tags
(click to filter results - removes previous filter)
children
efficacy
immunomodulation
monoclonal antibodies
multiple sclerosis
multiple sclerosis,children
multiple sclerosis,relapsing
multiple sclerosis,treatment of
natalizumab
safety
treatment of neurologic disorder
Click Here to return To Results